0001179110-20-001670.txt : 20200214
0001179110-20-001670.hdr.sgml : 20200214
20200214185446
ACCESSION NUMBER: 0001179110-20-001670
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KWON YOUNG
CENTRAL INDEX KEY: 0001733094
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 20622622
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS INC.
STREET 2: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2020-02-12
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001733094
KWON YOUNG
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial & Bus. Officer
Common Stock
2020-02-12
4
M
0
27500
A
139119
D
Common Stock
2020-02-13
4
S
0
9016
30.03
D
130103
D
Restricted Stock Units
2020-02-12
4
M
0
27500
0
D
Common Stock
27500
0
D
Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Restricted Stock Units convert into common stock on a one-for-one basis.
Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.
/s/ R.Mark Chamberlin as attorney in fact
2020-02-14